-Induces greater CDC-mediated tumor cell killing than that induced by daratumumab-Induces FcγR-mediated effector functions and effectively inhibits CD38 enzyme activity, thereby potentially contributing to immune activation. The gene discussed is FCGR2A; the disease is neoplasm.